DSO Sale: The $2.8M Private Equity Exit
Dr. Michael Torres received two offers for his $2.1 million practice in 2024. The first: $1.6 million from a traditional buyer—an associate dentist ready to buy her first practice. Cash at closing, simple structure, clean exit in 90 days. The second: $2.8 million from a private equity-backed DSO. $1.68 million cash at closing, plus $1.12 million in equity rollover, plus a 5-year employment contract at $285,000 annually, plus benefits, plus the potential for a second liquidity event when the DSO sold. The catch? He'd work for someone else. Clinical protocols would be standardized. Treatment planning would require approval over certain thresholds. His staff would report to regional management. His practice name would change. The "autonomy vs. payday" decision kept him up at night for three weeks. He chose the DSO. This guide gives you the complete DSO sale framework: the deal structures that create these premiums, the equity roll analysis that determines your real return, the employment contracts that bind you, and the cultural fit assessment that predicts whether you'll thrive—or regret—your decision.
The DSO Valuation Premium: Real Numbers
| Practice Type | Traditional Sale | DSO Sale | Premium |
|---|---|---|---|
| Single GP ($1.5M collections) | $975K (0.65x) | $1.35M (0.90x) | +39% |
| Multi-location GP ($4M) | $2.4M (6x EBITDA) | $4.0M (10x EBITDA) | +67% |
| Orthodontics ($2.5M) | $1.75M (0.70x) | $3.0M (1.20x) | +71% |
| Pediatric ($1.8M) | $1.26M (0.70x) | $2.34M (1.30x) | +86% |
Dr. Torres' $2.8M DSO Deal Structure
Practice Financials:
- Collections: $2,100,000
- EBITDA: $420,000 (20% margin)
- Valuation multiple: 6.67x EBITDA
Deal Structure:
- Cash at closing: $1,680,000 (60%)
- Equity rollover: $1,120,000 (40%)
- Total transaction value: $2,800,000
Employment Contract:
- Term: 5 years
- Base compensation: $225,000
- Production bonus (30%): $60,000
- Benefits: $25,000
- Annual total: $310,000
5-Year Economics:
- Cash at closing: $1,680,000
- 5 years compensation: $1,550,000
- Equity value (projected): $1,680,000
Total 5-year value: $4,910,000
vs. Traditional Sale:
- Sale proceeds: $1,365,000
- 5 years associate income: $1,125,000
Total 5-year value: $2,490,000
DSO advantage: $2,420,000 (97% more)
The Equity Roll: Risk or Opportunity?
DSOs require sellers to retain 20-40% equity. This creates alignment—but also risk.
The Equity Roll Analysis
Dr. Torres' $1.12M Equity Roll Scenarios
Scenario A: DSO Succeeds (Base Case)
- DSO grows from 50 to 150 practices in 5 years
- Enterprise value increases 3x
- His $1.12M equity becomes $3.36M
Return: 300%
Scenario B: DSO Moderate Growth
- DSO grows to 100 practices
- Enterprise value doubles
- His $1.12M equity becomes $2.24M
Return: 200%
Scenario C: DSO Struggles
- DSO faces integration challenges
- Enterprise value flat or down
- His $1.12M equity becomes $800K
Return: -29%
Scenario D: DSO Fails
- DSO declares bankruptcy
- Equity becomes worthless
- His $1.12M equity becomes $0
Return: -100%
The Tax Trap
Equity Roll Tax Timing Issues
Problem: Equity roll is often tax-deferred at closing—but you're taxed when the DSO sells (or you sell your equity).
Dr. Torres' tax timeline:
- Year 0: Taxed on $1.68M cash portion (capital gains)
- Year 5: Taxed on equity distribution (capital gains + possible ordinary income)
Risk: Tax rates may be higher in 5 years. No step-up in basis during employment.
Mitigation: Negotiate equity redemption rights, 83(b) elections where applicable.
The Employment Contract: What You're Really Signing
DSO employment isn't like being an associate. It's corporate dentistry with strings attached.
Standard DSO Employment Terms
| Term | Typical Range | Negotiable? |
|---|---|---|
| Contract length | 3-5 years | Sometimes |
| Base salary | $180K-250K | Yes |
| Production percentage | 25-35% | Sometimes |
| Minimum guarantee | Year 1-2 | Yes |
| Non-compete | 2-3 years, 5-10 miles | Rarely |
| Patient care standards | DSO protocols | No |
| Treatment approval | Required over $X | Sometimes |
| Working hours | DSO schedule | Sometimes |
| Malpractice | DSO provides | No |
| Benefits | Standard package | Limited |
The "For Cause" Termination Risk
If you're terminated "for cause," you may lose:
- Unvested equity (clawback provisions)
- Pro-rata bonus payments
- Benefits continuation
- Non-compete still applies
Common "for cause" triggers:
- License suspension (even temporary)
- Material breach of contract
- Conviction of crime
- Patient abandonment
- Fraud or theft
- Repeated policy violations
The DSO Sale Process: 6-Month Reality
| Phase | Timeline | Key Activities |
|---|---|---|
| Preparation | Month 1 | Clean financials, compliance audit, legal prep |
| Marketing | Month 2 | Reach out to DSOs, NDAs, preliminary conversations |
| Indications of Interest | Month 3 | Receive IOIs, select 3-5 for deeper review |
| Management Presentations | Month 4 | Practice tours, financial disclosure, meet leadership |
| Letter of Intent | Month 5 | Negotiate LOI, sign exclusivity, begin diligence |
| Due Diligence | Month 5-6 | Chart audits, compliance review, legal docs |
| Closing | Month 6+ | Final docs, employment contract, transition |
The DSO Landscape: Who's Buying
| DSO Category | Examples | Typical Offer | Culture |
|---|---|---|---|
| Megacorp ($1B+) | Heartland, Aspen | High valuation, rigid | Corporate, metrics-driven |
| Regional ($100M-1B) | Various regional groups | Good valuation, flexible | Semi-autonomous |
| Emerging ($10-100M) | Newer PE-backed | Highest valuations | Entrepreneurial |
| Doctor-Led | Doctor partnerships | Moderate, equity-heavy | Clinical-focused |
Is a DSO Sale Right for You?
Good Fit Indicators
- ✓ Practice EBITDA over $300K
- ✓ Willing to work 3-5 more years
- ✓ Tired of management responsibilities
- ✓ Open to clinical standardization
- ✓ Want premium valuation
- ✓ Comfortable with corporate environment
- ✓ Multiple locations (platform potential)
- ✓ Young enough for equity upside timeline
Poor Fit Indicators
- ✗ Want immediate retirement
- ✗ Value complete clinical autonomy
- ✗ Practice EBITDA under $200K
- ✗ Strong local referral relationships
- ✗ Staff are like family (will resist changes)
- ✗ Hate corporate structure
- ✗ Unwilling to relocate equity risk
- ✗ Close to retirement age
Maximizing DSO Value
Pre-Sale Preparation (12-18 Months)
- Clean financials: Audited statements command 10-15% premium
- Compliance audit: HIPAA, OSHA, state board—zero deficiencies
- Document systems: SOPs for everything reduce transition risk
- Growth trajectory: DSOs pay for future, not just current earnings
- Provider diversification: Multiple dentists reduce key-person risk
- Technology upgrade: Modern tech signals scalable platform
Competitive Process Strategy
Don't take the first offer. Engage 3-5 DSOs:
- Create bidding competition
- Compare deal structures
- Evaluate cultural fit
- Assess equity upside
- Negotiate employment terms
The Integration Reality
What happens after closing:
Month 1-3: Integration
- Software conversion
- Policy training
- Staff meetings with regional manager
- Insurance credentialing transition
- Supply chain changes
Month 4-12: Optimization
- Schedule standardization
- Fee schedule adjustments
- Marketing changes
- Staff performance reviews
- Protocol compliance audits
Year 2+: Operations
- You're an employee
- Regional manager oversight
- Quarterly business reviews
- Bonus calculations
- Equity tracking
Bottom Line
Dr. Torres chose the DSO and its $2.4M+ additional value. Three years in, he works 4 days a week, doesn't manage staff drama, and his equity has appreciated 40%. He's happy.
Another dentist in his market chose the same DSO, hated the loss of autonomy, tried to leave, and discovered his non-compete blocked him from practicing within 15 miles. He's miserable.
The DSO decision framework:
- Calculate total return (cash + equity + employment)
- Assess your risk tolerance for equity roll
- Evaluate cultural fit honestly
- Understand employment terms completely
- Get multiple offers to compare
- Hire dental M&A attorney (not generalist)
- Plan for 3-5 year commitment
- Decide if autonomy or payday matters more
The premium is real. So are the tradeoffs. Choose wisely.
Considering a DSO sale? Contact DentalBridge for DSO valuation and offer analysis.